Press release
Gene Silencing Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
Gene Silencing
_x000D_
What Is the Expected Gene Silencing Market Size During the Forecast Period?_x000D_
The size of the gene silencing market has expanded at a swift pace over the past few years. Its growth will see an increase from $5.97 billion in 2024 to $6.75 billion in 2025, with a compound annual growth rate (CAGR) of 13.0%. This substantial growth during the historical period can be ascribed to the burgeoning research in genetic therapies, preliminary RNA interference breakthroughs, a surge in the occurrence of genetic disorders, escalated investments in biotechnology, and the expansion of biopharmaceutical manufacturing potential._x000D_
_x000D_
The market for gene silencing is anticipated to experience significant expansion in the coming years, estimated to reach a value of $10.95 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.9%. The predicted surge during the forecast period could be due to the widening scope of applications in rare diseases, advances in delivery systems technology, burgeoning demand for personalized medicine, facilitating government programs, and increasing collaborations between pharmaceutical and biotech enterprises. Some noteworthy trends for the forecast period encompass the advent of focused gene therapies, the emergence of CRISPR-based silencing techniques, an increased emphasis on rare and orphan diseases, the breakthrough of nanoparticle delivery methods, and growing involvement in agriculture-related gene silencing applications._x000D_
_x000D_
Purchase the full report for exclusive industry analysis:_x000D_
https://www.thebusinessresearchcompany.com/customise?id=24224&type=smp_x000D_
_x000D_
What Are the High-Growth Segments in the Gene Silencing Market?_x000D_
The gene silencing market covered in this report is segmented -_x000D_
_x000D_
1) By Type: Transcriptional, Post-Transcriptional, Meiotic_x000D_
2) By Gene Silencing: RNA Interference (RNAi), Antisense Oligonucleotides (ASOs), Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing, Other Gene Silencings_x000D_
3) By Application: Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Other Applications_x000D_
4) By End-Users: Pharmaceutical And Biotechnology Companies, Research Institutes and Academic Centers, Hospitals, Clinics, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Transcriptional: DNA Methylation, Histone Modification_x000D_
2) By Post-Transcriptional: RNA Interference (RNAi), Antisense Oligonucleotides, MicroRNA (miRNA) Mediated Silencing_x000D_
3) By Meiotic: Meiotic Gene Conversion, Transposable Element Silencing_x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=24224&type=smp_x000D_
_x000D_
What Key Drivers Are Expected to Influence Future Gene Silencing Market Growth?_x000D_
The anticipated growth of the gene silencing market is commonly linked to the increasing instances of genetic disorders. Genetic disorders, which are health conditions prompted by DNA abnormalities in an individual, are being recognized more frequently. This increasing identification is a result of advances in diagnostic technology, a rise in awareness and wider access to genetic testing. Factors such as rising parental age contribute to higher rates of genetic disorders, as this heightens the risk of passing genetic mutations to offspring. Gene silencing represents a potential treatment involving the selective halting of expression of defective or disease-causing genes. As an illustration from August 2023, approximately 1 in every 800 newborns in the UK is affected by Down Syndrome according to Down Syndrome UK, a domestic nonprofit organization. Meanwhile, an estimated 40,000 individuals in the UK are affected by this disorder. Thus, it is the higher incidence of genetic disorders that is boosting the expansion of the gene silencing market._x000D_
_x000D_
Which Companies Hold the Largest Share Across Different Gene Silencing Market Segments?_x000D_
Major companies operating in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc._x000D_
_x000D_
What Trends Are Expected to Dominate the Gene Silencing Market in the Next 5 Years?_x000D_
Leading firms in the gene silencing market are prioritizing the development of groundbreaking technologies like small interfering RNA (siRNA) to increase precision and effectiveness in gene therapy. Small interfering RNA (siRNA) is an RNA molecule that holds an essential role in the RNA interference (RNAi) pathway. It binds to specific messenger RNA (mRNA) and facilitates its degradation, stopping the creation of proteins that cause diseases. For example, in October 2024, Judo Bio Inc., a biotechnology firm based in the United States, introduced siRNA, a new generation drug that employs small interfering RNA (siRNA) to suppress genes. The drug stands out for its unique features such as proprietary delivery systems like lipid nanoparticles or conjugated ligands, ensuring efficient absorption by certain cells or tissues, and AI-powered platforms hastening the finding of feasible gene targets._x000D_
_x000D_
Get the full report for exclusive industry analysis:_x000D_
https://www.thebusinessresearchcompany.com/report/gene-silencing-global-market-report_x000D_
_x000D_
What Are the Emerging Geographies for The Gene Silencing Market Growth?_x000D_
North America was the largest region in the gene silencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene silencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
Frequently Asked Questions:_x000D_
1. What Is the Market Size and Growth Rate of the Gene Silencing Market?_x000D_
2. What is the CAGR expected in the Gene Silencing Market?_x000D_
3. What Are the Key Innovations Transforming the Gene Silencing Industry?_x000D_
4. Which Region Is Leading the Gene Silencing Market?_x000D_
_x000D_
Why This Report Matters:_x000D_
_x000D_
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors._x000D_
_x000D_
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends._x000D_
_x000D_
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene Silencing Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts here
News-ID: 4060560 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
